Bioline Rx reported $-977K in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Arca Biopharma USD -29.58M 694K Dec/2025
Bio Path USD -4.6M 1.74M Jun/2025
Bioline Rx USD -977K 2.96M Sep/2025
Capricor Therapeutics USD -30.17M 5.6M Dec/2025